Mylan Challenge To “Authorized” Generics May Shift To Antitrust Arguments
Executive Summary
Mylan could turn to antitrust laws as an avenue for renewing a court challenge against "authorized" generics after dropping its lawsuit against FDA
You may also be interested in...
Duragesic Competition Could Add To Mylan’s “Authorized” Generics Fight
The anticipated launch of an "authorized" generic of J&J's Duragesic could give Mylan further ammunition in its ongoing fight against such products
Duragesic Competition Could Add To Mylan’s “Authorized” Generics Fight
The anticipated launch of an "authorized" generic of J&J's Duragesic could give Mylan further ammunition in its ongoing fight against such products
“Authorized” Generics Are “Legitimate Business Strategy,” Pfizer Says
Pfizer views "authorized" generics as a sound business strategy following a drug's patent expiration, Senior Corporate Counsel Jeffrey Chasnow said during a Drug & Device Dialogue audio conference Oct. 7